{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-2/paragraph-23",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-2/paragraph-23.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/2/paragraph/23",
  "kind": "paragraph",
  "number": "23",
  "heading": "Additional matters for consideration in relation to applications for inclusion in a pharmaceutical list",
  "text": "(1) In the case of a routine or excepted application by a person (A) for inclusion in a pharmaceutical list who is not already included in it, NHS England must, prior to determining the application—\n(a) check with the NHS CFA whether A, and if A is a body corporate whether any director or superintendent of A, has any record of, or is under investigation for, fraud;\n(b) check with the Secretary of State whether the Secretary of State holds any information about A, and if A is a body corporate about any director or superintendent of A, that is relevant to its consideration of whether—\n(i) the application should be refused or deferred under regulations 33 or 34, or\n(ii) conditions should be imposed under regulation 35;\n(c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(2) In such a case, having considered whether—\n(a) the application should be refused or deferred under regulations 33 or 34; or\n(b) conditions should be imposed under regulation 35,\nif it is minded to impose conditions under regulation 35, it must notify A at least 7 days in advance of determining that it is to impose such conditions and consider any representations (which may be at an oral hearing) that A makes prior to the determination with regard to the notification.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Sch. 2 para. 23(1)(a) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 8(3)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Sch. 2 para. 23(1)(c) omitted (1.10.2024) by virtue of The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2024 (S.I. 2024/894), regs. 1(3), 3(3)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/2/paragraph/23",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}